IHS Chemical Week

People & Business :: Companies

Bayer Sues Teva for Patent Infringement

1:44 AM MDT | July 2, 2009 | Natasha Alperowicz

Bayer Schering Pharma AG,  Bayer HealthCare Pharmaceuticals Inc., and Schering Corporation have jointly filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Ltd. The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra, Bayer Schering Pharma's therapy for the treatment of erectile dysfunction, prior to patent expiration. Bayer says the patent at issue is Bayer Schering Pharma's U.S. Patent No. 6,362,178...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa